Medicine
Desmopressin 4 mcg/1 mL injection
Desmopressin 4 mcg/1 mL injection is a generic prescription medicine for intravenous, subcutaneous use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated 2° to 8°C (36° to 46°F).
Key facts
- Active ingredient (INN)
- Desmopressin
- Brand
- Sold under the generic name
- Strength
- 4 mcg/1 mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Packs
- 10 ampules of 1 mL, 10 vials of 1 mL and 8 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaGland PharmaIndiaSun Pharmaceutical IndustriesIndiaUBI PharmaArmas PharmaceuticalsAvenacyFresenius KabiMeitheal PharmaceuticalsSagent PharmaceuticalsXGen Pharmaceuticals DJB
- Origin register
- US FDA, United States
- Storage
- Store refrigerated 2° to 8°C (36° to 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01BA02 Desmopressin
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 March 2018
- Identifiers
- RxCUI 849501, 1723232DailyMed set ID b01c22dc-eecd-11b2-e053-2a95a90a529a, cdec2cc2-4fd9-474e-884f-d0599e40948f, 1052a869-b64d-655d-e063-6294a90ad0e2 +8NDC 72843-461, 70095-026, 39822-6200 +8Application ANDA210223, ANDA216922, ANDA074888 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 ampule in 1 box / 1 mL in 1 ampule | 43598-931-09 | Dr. Reddy's LaboratoriesIndia | 3 April 2020 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 68083-550-10 | Gland PharmaIndia | 16 November 2022 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70095-026-02 | Sun Pharmaceutical IndustriesIndia | 3 April 2023 |
| 10 ampule in 1 box / 1 mL in 1 ampule | 72843-459-10 | UBI Pharma | 14 February 2020 |
| 10 vial in 1 carton / 1 mL in 1 vial | 72843-461-10 | UBI Pharma | 17 September 2020 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72485-523-10 | Armas Pharmaceuticals | 30 June 2026 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 65219-293-01 | Fresenius Kabi | 11 September 2023 |
| 10 vial in 1 carton / 1 mL in 1 vial | 71288-440-02 | Meitheal Pharmaceuticals | 13 February 2026 |
| 10 vial in 1 carton / 1 mL in 1 vial | 25021-460-01 | Sagent Pharmaceuticals | 15 March 2018 |
| 10 vial in 1 carton / 1 mL in 1 vial | 39822-6200-2 | XGen Pharmaceuticals DJB | 22 March 2024 |
| 10 vial in 1 carton / 1 mL in 1 vial | 83634-451-01 | Avenacy | 15 October 2025 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 65145-183-10 | — | 16 March 2026 |
| 1 mL in 1 ampule | 69918-899-01 | — | 20 January 2016 |
| 10 ampule in 1 carton / 1 mL in 1 ampule | 69918-899-10 | — | 20 January 2016 |
| 10 ampule in 1 carton / 1 mL in 1 ampule | 69918-899-11 | — | 7 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 February 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Desmopressin 4 mcg/1 mL injection.
Other strengths and forms of Desmopressin
Clinical summary
Desmopressin is a factor VIII activator indicated for the treatment of nephrogenic diabetes insipidus, among other approved uses. It is available as injection, tablets and nasal solution for intravenous, subcutaneous and oral use. MedsAcross supplies Desmopressin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DesmopressinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Desmopressin Acetate prescribing information (Nordic Pharma) · U.S. National Library of Medicine, DailyMed
Need Desmopressin 4 mcg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.